Functional Interactions between Retinoblastoma and c-MYC in a Mouse Model of Hepatocellular Carcinoma
Open Access
- 6 May 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (5), e19758
- https://doi.org/10.1371/journal.pone.0019758
Abstract
Inactivation of the RB tumor suppressor and activation of the MYC family of oncogenes are frequent events in a large spectrum of human cancers. Loss of RB function and MYC activation are thought to control both overlapping and distinct cellular processes during cell cycle progression. However, how these two major cancer genes functionally interact during tumorigenesis is still unclear. Here, we sought to test whether loss of RB function would affect cancer development in a mouse model of c-MYC-induced hepatocellular carcinoma (HCC), a deadly cancer type in which RB is frequently inactivated and c-MYC often activated. We found that RB inactivation has minimal effects on the cell cycle, cell death, and differentiation features of liver tumors driven by increased levels of c-MYC. However, combined loss of RB and activation of c-MYC led to an increase in polyploidy in mature hepatocytes before the development of tumors. There was a trend for decreased survival in double mutant animals compared to mice developing c-MYC-induced tumors. Thus, loss of RB function does not provide a proliferative advantage to c-MYC-expressing HCC cells but the RB and c-MYC pathways may cooperate to control the polyploidy of mature hepatocytes.This publication has 77 references indexed in Scilit:
- Stage-specific sensitivity to p53 restoration during lung cancer progressionNature, 2010
- Selective activation of p53-mediated tumour suppression in high-grade tumoursNature, 2010
- Division and apoptosis of E2f-deficient retinal progenitorsNature, 2009
- The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-RasOncogene, 2009
- Tailoring to RB: tumour suppressor status and therapeutic responseNature Reviews Cancer, 2008
- Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivationProceedings of the National Academy of Sciences of the United States of America, 2007
- Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switchProceedings of the National Academy of Sciences of the United States of America, 2006
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 2004
- The Hallmarks of CancerCell, 2000